Hypertriglyceridaemia during low-dose interferon alpha-2b treatment in a patient with Kaposi's sarcoma.
Alexandropoulos
E C
EC
Kontochristopoulos
G J
GJ
Zakopoulou
N
N
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005121:Extremities; D006801:Humans; D015228:Hypertriglyceridemia / Q000139:chemically induced*; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D013909:Thorax; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D016898:Interferon-alpha; D014750:Vincristine; D014747:Vinblastine